Childhood body mass index growth trajectories and endometrial cancer risk by Aarestrup, Julie et al.
                          Aarestrup, J., Gamborg, M., Tilling, K., Ulrich, L. G., Sørensen, T. I. A., &
Baker, J. (2017). Childhood body mass index growth trajectories and
endometrial cancer risk. International Journal of Cancer, 140(2), 310–315.
https://doi.org/10.1002/ijc.30464
Publisher's PDF, also known as Version of record
License (if available):
CC BY-NC-ND
Link to published version (if available):
10.1002/ijc.30464
Link to publication record in Explore Bristol Research
PDF-document
This is the final published version of the article (version of record). It first appeared online via Wiley at
http://onlinelibrary.wiley.com/doi/10.1002/ijc.30464/abstract. Please refer to any applicable terms of use of the
publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms

Childhood body mass index growth trajectories and
endometrial cancer risk
Julie Aarestrup1, Michael Gamborg1, Kate Tilling2, Lian G. Ulrich3, Thorkild I.A. Sørensen1,4 and Jennifer L. Baker1,4
1 Institute of Preventive Medicine, Bispebjerg and Frederiksberg Hospital, The Capital Region, Copenhagen, Denmark
2 School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom
3Department of Gynecology and Obstetrics, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
4Novo Nordisk Foundation Center for Basic Metabolic Research, Section on Metabolic Genetics, Faculty of Health and Medical Sciences, University of
Copenhagen, Copenhagen, Denmark
Previously, we found that excess weight already in childhood has positive associations with endometrial cancer; however,
associations with changes in body mass index (BMI) during childhood are not well understood. Therefore, we examined
whether growth in childhood BMI is associated with endometrial cancer and its sub-types. A cohort of 155,505 girls from the
Copenhagen School Health Records Register with measured weights and heights at the ages of 6–14 years and born 1930–
1989 formed the analytical population. BMI was transformed to age-specific z scores. Using linear spline multilevel models,
each girl’s BMI growth trajectory was estimated as the deviance from the average trajectory for three different growth periods
(6.25–7.99, 8.0–10.99, 11.0–14.0 years). Via a link to health registers, 1,020 endometrial cancer cases were identified, and
Cox regressions were performed. A greater gain in BMI during childhood was positively associated with endometrial cancer
but no differences between the different growth periods were detected in models adjusted for baseline BMI. The hazard ratios
for the associations with overall growth during childhood per 0.1 z score increase were 1.15 (95% confidence interval [CI]:
1.07–1.24) for all endometrial cancers, 1.12 (95% CI: 1.04–1.21) for estrogen-dependent cancers, 1.16 (95% CI: 1.06–1.26)
for endometrioid adenocarcinomas and 1.46 (95% CI: 1.16–1.84) for non-estrogen-dependent cancers. Growth in BMI in early
life is positively linked to later endometrial cancer risk. We did not identify any sensitive childhood growth period, which sug-
gests that excess gain in BMI during the entire childhood period should be avoided.
Endometrial cancer is a common gynecologic malignancy
among women, especially in developed countries.1 It is esti-
mated that >319,000 women worldwide are diagnosed with
this disease per year,2 and the number is likely to increase
with the ageing of populations and the current pandemic lev-
els of overweight and obesity. Greater adult adiposity is a key
risk factor for endometrial cancer, especially tumors that are
estrogen dependent.1,3 In a previous study, we showed that
excess adiposity already in childhood has positive associations
with endometrial cancer later in life,4 suggesting that body
size development in early life may contribute to the associa-
tions found for adult adiposity.
Weight gain in adulthood is positively linked to the risk of
endometrial cancer.5,6 Previous studies have found associations
between childhood body mass index (BMI) growth patterns
and morbidity and mortality in adult life.7–11 Thus, it is plausi-
ble that BMI growth trajectories in early life may be associated
with long-term health consequences such as endometrial
malignancies, either through an early establishment of carcino-
genic processes or through tracking of BMI into adult life.12
A better understanding of such patterns, if they exist, is
important for establishing the timing at which associations with
excess adiposity emerge. Additionally, investigations of early life
BMI growth and its impact on later disease risk add to the poten-
tial for identifying whether there exist sensitive periods during
childhood for the development of endometrial malignancies.
Therefore, using repeated measured values of height and
weight at different childhood ages from a population-based
cohort, we investigated if growth in childhood BMI is associ-
ated with endometrial cancer and its sub-types.
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Material and Methods
Study population
Women came from the Copenhagen School Health Records
Register (CSHRR), which has previously been described in
detail elsewhere.13 In brief, school children in the municipali-
ty of Copenhagen, born 1930–1989, underwent annual man-
datory health examinations through 1983 and thereafter only
at school entrance and exit. These examinations were
performed by a medical doctor or a nurse who measured the
children’s heights and weights. This information has been
computerized, and there was a maximum of 12 measures
entered per child.13 BMI was calculated and transformed into
z scores using the Lamda, Median, Sigma (LMS) method,14
based upon an internal age- and sex-speciﬁc reference.15
Data linkage
All Danish residents alive or born after 2 April 1968 were
assigned a unique identiﬁcation number by the Danish Civil
Registration System.16 Children who attended school at this
time or later had their identiﬁcation number recorded on
their health card and identiﬁcation numbers were retrieved
for those who left school prior to this time. Identiﬁcation
numbers were successfully linked for 88% of the children.13
These identiﬁcation numbers enable linkages to national
health registers for follow-up.
Study outcomes
Incident endometrial cancers were identiﬁed through linkage
to the national Danish Cancer Registry and classiﬁed using
the International Classiﬁcation of Disease (ICD)-10 codes,
which were available from 1978 onward due to a recording
project at the Registry.17 The following codes were used to
deﬁne endometrial cancer: C54.0–C54.1, C54.3–C54.6, C54.9
and C55.9. Based on ICD-O-3 morphology codes, endometri-
al cancers were further classiﬁed as estrogen-dependent,
including the sub-type of endometrioid adenocarcinoma, and
non-estrogen-dependent cancers.4 Few tumors could not be
classiﬁed as either type (N5 8). Vital status was obtained by
linkage to the national Danish Civil Registration System16
and hysterectomy information by linkage to the Danish
National Patient Register, which contains computerized infor-
mation on all hospital discharge diagnoses from 1977
onwards.18
Women eligible for our study were born from 1930 to
1989, had an identiﬁcation number, were alive and living in
Denmark on 1 January 1978 and were aged 18 years or older.
From the starting population of 184,276 women, 158,751
women fulﬁlled these criteria. The largest reason for ineligi-
bility was lacking an identiﬁcation number (n5 21,717), and
this was due to reasons including death before 1968, emigra-
tion or spelling errors in the records that precluded us from
retrieving the number.13 From the eligible women, exclusions
were made for those with a hysterectomy prior to 1978
(n5 525) or age 18 (n5 5), an endometrial cancer diagnosis
prior to 1978 (n5 10) or missing a date at diagnosis (n5 1),
no height and/or weight measures in childhood (n5 2,701)
or an outlying BMI or height value at all childhood ages
(z scores< or >4.5; n5 4). Each woman was followed from
the age of 18 years or from her age in 1978, whichever came
later. Women were followed up until a diagnosis of endometrial
cancer, hysterectomy, death, emigration, loss to follow-up, or 31
December 2012, whichever came ﬁrst.
Statistical analyses
Linear spline multilevel models19 were used to estimate child-
hood BMI growth trajectories from age 6.25 years to 14.0
years for all girls with at least one weight and height mea-
surement between these ages under a missing at random
assumption. The multilevel model has two levels: measure-
ment occasion (Level 1) and individual (Level 2). The
occasion-level residuals estimate the measurement error in
the BMI values and the individual-level residuals represent
an individual’s BMI growth pattern.
The rate of change in BMI z scores was modeled as three
linear splines with knot points positioned at ages 8.0 and
11.0 years as these are approximately mid-way through the
age range included in our study. Additionally, these knot
points allowed for a sufﬁcient number of girls in each age
group. The baseline level was set at 7.0 years in all models.
The deviance from average for each child (i.e., individual-
level residuals) was estimated for every age period as deﬁned
by the knot points (6.25–7.99, 8.0–10.99 and 11.0–14.0 years).
Furthermore, we included an interaction with birth cohort
(10-year intervals), thus allowing the baseline and slopes of
the linear splines to vary by birth cohort.
We evaluated how well the model ﬁtted the data by calcu-
lating the BMI z scores predicted by the model and compar-
ing these with observed values (Supporting Information
Table S1).We found a high agreement for all three growth
periods. Further, we conducted sensitivity tests excluding
women with few or many childhood measures (5 or 10).
We found that the results were generally similar to those
What’s new?
High body mass index (BMI) early in life is linked to an increased risk of endometrial cancer in adulthood. Potentially influenc-
ing that association are the amount by which BMI increases in childhood, as well as the timing of BMI increase. Here, analy-
ses of data from the Copenhagen School Health Records Register for girls ages 6 to 14 shows that endometrial cancer risk is
increased by greater BMI gain across ages, while the specific age at which BMI increases occurs has little impact. Excess BMI
gain at any time during childhood could set the stage for endometrial carcinogenesis.
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from the entire sample (not shown), suggesting that the miss-
ing at random assumption underlying the multilevel models
is likely to hold.
The individual-level estimates (baseline and BMI growth
parameters) were then included in Cox proportional hazard
regressions to investigate the associations with endometrial
cancer in adulthood. We used age as the underlying time
scale and analyses were stratiﬁed by 5-year birth cohorts. We
performed a series of conditional analyses using the following
models: (i) the baseline level only (indicating young child-
hood body size), (ii) the baseline level plus the ﬁrst (6.25–
7.99 years) childhood BMI growth period, (iii) the baseline
level plus the ﬁrst and second (8.0–10.99 years) childhood
BMI growth periods and (iv) the baseline level plus the ﬁrst,
second and third (11.0–14.0 years) BMI growth periods.
The linearity of the associations was assessed by linear
splines with two knots at BMI z scores of 60.68. We
detected statistically signiﬁcant non-linearity for associations
between the BMI baseline level (in models unadjusted and
adjusted for childhood BMI growth) and all endometrial can-
cers, estrogen-dependent cancers and endometrioid adenocar-
cinomas. Therefore, we modeled the non-linearity using
linear splines with a z score of 0 as reference and we present
point estimates for z scores of 61.0 equivalent to approxi-
mately the 16th and 84th percentiles. Deviations from linearity
were not detected in the associations between the BMI base-
line level and non-estrogen-dependent cancers. Similarly, we
did not identify indications of non-linearity in the associa-
tions between childhood BMI growth parameters and all
endometrial cancer forms. Therefore, the associations
between BMI growth and endometrial cancer are shown per
0.1 z score increase as this was approximately the standard
deviation in BMI growth for each age period.
Using a Chi-squared test, we investigated if the associa-
tions between each of the three BMI growth parameters
(6.25–7.99, 8.0–10.99, 11.0–14.0 years) and endometrial can-
cer differed from each other. As we did not ﬁnd indications
of signiﬁcant differences (all conﬁdence intervals included 1)
we additionally constructed a combined BMI growth estimate
(averaging the three BMI growth residuals adjusting for the
baseline level) to express average BMI growth during
childhood. We then examined the associations with endome-
trial cancer using a model including the BMI baseline level
and the combined BMI growth estimate.
We examined the proportional hazards assumptions
underlying the Cox models by testing if associations between
baseline BMI and growth in childhood BMI, respectively, and
endometrial cancer differed within categories of age at diag-
nosis (quartiles with approximately the same number of cases
in each category) using likelihood ratio tests. Interactions of
birth cohort with the associations between baseline BMI and
growth in childhood BMI, respectively, and endometrial can-
cers were similarly investigated using likelihood ratio tests.
We did not identify violations of the proportional hazards
assumption or birth cohort effects in any of the associations.
Statistical analyses were performed using Stata (version
12.1, StataCorp LP College Station, TX) and MLwiN (version
2.26) via Stata.
Our study was approved by the Danish Data Protection
Agency. According to Danish law, ethical approval is not
required for register-based studies.
Results
In total, 155,505 women were included in our study and
there were 994,287 childhood body size measurements. The
median number of routine weight and height measures was 7
(5–95 percentiles: 2–9). Across the birth years included in
our study, average-sized 7-year-old girls (approximately
23 kg, median heights of 120–124 cm) gained 20–23 kg and
increased in height by 32–35 cm from 7 to 13 years of age.
During 4.1 million person-years of follow-up, 1,020 women
were diagnosed with endometrial cancer, of which 920 were
estrogen-dependent cancers (among these 659 were endome-
trioid adenocarcinomas), 92 were non-estrogen-dependent
cancers and 8 cancers could not be classiﬁed as either type.
Body size at the youngest childhood ages (expressed by
the baseline only model) had non-linear associations with
endometrial cancer, except for non-estrogen-dependent endo-
metrial cancer (Table 1). Thus, girls with a BMI z score of 1
or above at the youngest childhood ages had a higher risk of
all endometrial cancers, estrogen-dependent cancers and
endometrioid adenocarcinoma compared to girls with a BMI
Table 1. Point estimates for the associations between young childhood body size (baseline size only, age 7 years) and all endometrial can-
cers, estrogen-dependent cancers and endometrioid adenocarcinomas1
BMI z scores
21.0
0
1.0
Type HR 95% CI HR HR 95% CI p-Value2
All combined 0.98 0.88–1.08 1.00 (ref.) 1.18 1.08–1.30 0.009
Estrogen-dependent 0.99 0.89–1.10 1.00 (ref.) 1.19 1.09–1.31 0.001
Endometrioid adenocarcinoma 0.95 0.84–1.08 1.00 (ref.) 1.27 1.13–1.42 0.01
1Stratified by 5-year birth cohorts. BMI baseline level was modeled using linear splines with two knots at z scores of 60.68.
2Test for linearity using a likelihood ratio test.
BMI: Body mass index, CI: Confidence interval, HR: Hazard ratio.
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z score of 0 (Table 1). In contrast, no associations with endo-
metrial cancer were found for girls with a BMI z score below
0 (Table 1).
Associations between BMI growth at the three different
periods during childhood and all endometrial cancers,
estrogen-dependent cancers and endometrioid adenocarcino-
mas were consistently positive but several of the conﬁdence
intervals included 1 (Fig. 1). Although the second period of
BMI growth (8.0–10.99 years) had positive associations with
all cancer types, these associations did not differ signiﬁcantly
from the other BMI growth periods (all conﬁdence intervals
for the tests of the comparisons included 1) that we investi-
gated (Fig. 1). When averaging the childhood BMI growth
parameters into a combined estimate (modeled by the com-
bined growth parameter adjusted for baseline size), the asso-
ciations with all types of endometrial cancer were positive
and the conﬁdence intervals did not include 1 (Fig. 1).
For the rare (N5 92) type of non-estrogen-dependent
endometrial cancer, we found indications of associations with
young childhood body size (Table 2). Furthermore, although
some evidence supported that childhood BMI growth had
positive associations with non-estrogen-dependent endome-
trial cancers, and the ﬁrst BMI growth period in particular,
the associations were not signiﬁcantly different from each
other (p values5 0.84). Additionally, due to the low number
of cases the conﬁdence intervals were wide (Table 2).
Discussion
In our study, we prospectively assessed the associations
between BMI growth trajectories in childhood and adult
endometrial cancer. Our results indicate that a greater gain
in childhood BMI is positively associated with later endome-
trial cancer. Aside from the overall BMI gain from 6.25 to
14.0 years, we did not identify any sensitive BMI growth
periods during this age span which had associations with
adult endometrial cancer.
Previously we found that childhood BMI at ages 7–13
years had positive associations with endometrial cancer risk
and that the associations were particularly strong for the
estrogen-dependent endometrial cancer forms and that these
associations were unaffected by adjustment for adult hor-
mone replacement therapy use.4 In our study, we similarly
found that body size at the youngest ages increased the risk
of all endometrial cancers except for the rare non-estrogen-
dependent cancers. Whether these associations operate
through the early establishment of carcinogenic processes or
by putting girls on a growth trajectory that leads to adult
overweight remains to be elucidated. Nonetheless, in a previ-
ous study we found that childhood BMI is relatively poor at
identifying later adult overweight at ages when most endome-
trial cancers emerge, suggesting that childhood BMI and
growth may have independent associations with later endo-
metrial cancer.12
Our results suggest that growth in childhood BMI is
important for the future risk of endometrial cancer and its
sub-types. All associations with the different growth periods
were positive and did not differ from each other. Studies on
adult body size suggest that weight gain after age 18 years is
positively associated with endometrial cancer.5,6 Nonetheless,
we cannot disentangle if excess weight gain already in child-
hood or weight gain more proximal to an endometrial cancer
diagnosis is most important for the future risk of endometrial
cancer as we did not have adult size available in our study.
Growth in childhood BMI reﬂects genetics and the envi-
ronment in which the child was born into and grew up in.20
Thus growth in BMI is an indicator of risk and is not neces-
sarily the causative factor for endometrial cancer. Our study
included girls born from 1930 to 1989, thus although few
Table 2. Young childhood body size (baseline size only) and child-
hood BMI growth adjusted for baseline size and previous growth
periods and the associations with non-estrogen-dependent endome-
trial cancer per 0.1 z score increase in each period1
Hazard ratio
95% Confidence
interval
Baseline (7 years) 1.01 0.98–1.03
Growth period (years)
6.25–7.99 1.17 1.05–1.30
8.0–10.99 1.15 0.94–1.40
11.0–14.0 1.10 0.90–1.34
Combined growth
(6.25–14.0 years)
1.46 1.16–1.84
BMI: Body mass index.
1Stratified by 5-year birth cohorts.
Figure 1. Childhood BMI (kg/m2) growth in each of the three age
periods adjusted for baseline size and the preceding growth peri-
od(s) and combined growth during childhood (6.25–14.0 years)
and associations with all endometrial cancers, estrogen-dependent
cancers and endometrioid adenocarcinomas per 0.1 z score
increase in each period and for the combined growth estimate
(Cox model stratified by 5-year birth cohorts).
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genetic changes occurred there were large environmental
changes with improved nutrition, medical care and social
conditions. We indirectly accounted for these factors by strat-
ifying the analyses by birth cohort as information on these
other factors was unavailable in our study. We found the
associations between child BMI growth and endometrial can-
cer did not differ by birth cohort; thus they were the same
for a girl born in 1930 as in 1940, and 1950 and so on. Tak-
en together with the results from our earlier study in girls
and those in women, these results suggest that the associa-
tions have biologic origins and do not only reﬂect social
conditions.
The underlying biological pathways for an association
between childhood BMI growth and endometrial cancer risk
are only speculative. A faster gain in childhood BMI leading to
a greater level of excess BMI is most likely associated with
increased levels of endogenous sex hormones and insulin resis-
tance as is suggested for adult adiposity.21,22 Thus, girls with
greater BMI gain already in childhood may be more suscepti-
ble to carcinogenic mechanisms through an enhanced cell pro-
liferation caused by a prolonged exposure period resulting in
an endometrial cancer diagnosis numerous years later.21,22
Strengths of our study include that it was undertaken in a
large population-based cohort of girls. The large number of
repeated measurements of height and weight allowed us to
assess whether there existed speciﬁc periods during the ages
of 6.25–14.0 years, which were associated with endometrial
cancer development. We used multilevel models to obtain
childhood BMI growth trajectories and these models have the
advantage of not being restricted to include measures at spe-
ciﬁc ages or to individuals with complete information on the
exposure variable.23
There are limitations to our study as well; children from
this historic cohort are relatively lean compared to contem-
porary children with approximately 7% of the girls in our
study being classiﬁed as overweight (including obesity) by the
Centers for Disease Control (CDC) 2000 growth reference.24
Accordingly, there is likely less variability in the BMI growth
patterns among girls in our study than may be observed
among more contemporary cohorts of girls. As a result, it is
possible that although a sensitive period was not detected in
our study, one may exist. Additionally, as the anthropometric
information available was measured at ages 6.25–14 years, we
are lacking information on very early childhood and late ado-
lescent BMI growth. Therefore, we cannot rule out that a
sensitive period exists before or after the included age range.
Further as information on early life factors which may be
associated with childhood BMI and endometrial cancer was
unavailable; we cannot explore what effect they may have on
the associations that we observed. In our study, we did not
have information available on the age at menarche or meno-
pause, both of which may affect a woman’s risk of endome-
trial cancer via exposure to endogenous sex hormones.25
Finally, our study population is based on girls who attended
school in Copenhagen and who are primarily Caucasian. As
our follow-up was virtually complete and nationwide due to
the register linkages, our ﬁndings are generalizable to all
Danish women and likely other Caucasian populations, but
they may not be generalizable to other ethnicities.
In conclusion, our ﬁndings suggest that a greater BMI
gain during childhood is associated with future risk of endo-
metrial malignancies. We did not detect a particularly sensi-
tive period for excess BMI gain in childhood from the ages
of 6.25–14.0 years. From a public health perspective our
study suggests that excess BMI should be avoided during the
entire childhood period to limit the later risk of adverse
health outcomes such as endometrial malignancies.
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